DESCRIPTION (provided by applicant): This Program Project Grant (PPG) will address how an "expanded neurovascular unit" responds to injury and putative therapeutic treatment in three major brain hemorrhagic disorders seen in neurosurgery service. The expanded neurovascular unit includes not only endothelial cells, pericytes, and astrocytes but also the feeding and upstream cerebral arteries of the neurovascular unit and arterial smooth muscle cells. The responses of the expanded neurovascular unit to hemorrhagic brain injury may not only demonstrate universal but also distinct pathophysiological features. In our PPG we propose a horizontal comparative study in rodent models o f t h e three major brain hemorrhage disorders, subarachnoid hemorrhage (SAH), intracerebral hemorrhage (ICH), and traumatic brain injury (TBI). Similarly we will compare three different treatment strategies such as osteopontin (OPN), anti-PDGF (Gleevec), and AP-Cav (caveolin) in all three distinct hemorrhagic brain injury models. Based upon existing literature combined with our own preliminary observations, our hypothesis is that there are universal but distinct features of injury encompassing the expanded neurovascular unit following brain hemorrhage in SAH/ICH/TBI models. We further hypothesize that three distinct neurovascular protection strategies targeting the matrix protein OPN, PDGF-receptors, and endothelial caveolin will prevent arterial smooth muscle phenotype changes, provide neurovascular protection to strengthen blood-brain barrier (BBB) integrity, improve vascular function and reduce brain edema via different mechanisms.
Public Health Relevance Statement
Public Health Relevance: This PPG will integrate expertise from cerebral hemorrhage, traumatic brain injury and vascular biology to study common features of an expanded neurovascular injury after subarachnoid hemorrhage, intracerebral hemorrhage and traumatic brain injury. Injuries will be mimicked in three rodent models while employing neuroimaging, neurobehavioral testing and vascular biology to compare common and distinct features. Using three treatment strategies in all models, our results have the potential to impact daily neurosurgery service.
National Institute of Neurological Disorders and Stroke
CFDA Code
853
DUNS Number
009656273
UEI
SZAKFNU35ZX5
Project Start Date
01-January-2014
Project End Date
31-December-2018
Budget Start Date
01-January-2014
Budget End Date
31-December-2014
Project Funding Information for 2014
Total Funding
$1,279,397
Direct Costs
$825,002
Indirect Costs
$454,395
Year
Funding IC
FY Total Cost by IC
2014
National Institute of Neurological Disorders and Stroke
$1,279,397
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1P01NS082184-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1P01NS082184-01A1
Patents
No Patents information available for 1P01NS082184-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1P01NS082184-01A1
Clinical Studies
No Clinical Studies information available for 1P01NS082184-01A1
News and More
Related News Releases
No news release information available for 1P01NS082184-01A1
History
No Historical information available for 1P01NS082184-01A1
Similar Projects
No Similar Projects information available for 1P01NS082184-01A1